Skip to main content

Table 3 Treatments administered

From: Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

 

Arm A

Arm B

Total number of cycles

149

148

   Median number of cycles (min-max)

3 (1–8)

3 (1–6)

No. of delayed cycles (%)

22 (14.8)

9 (6.1)

Median dose intensity

0.78

0.86